
1. aids. 1994 jun;8(6):741-5.

high serum level soluble form cd30 molecule early phase hiv-1
infection independent predictor progression aids.

pizzolo g(1), vinante f, morosato l, nadali g, chilosi m, gandini g, sinicco a,
raiteri r, semenzato g, stein h, et al.

author information: 
(1)department haematology, policlinico borgo roma, verona university school of
medicine, italy.

objective: determine serum levels soluble form cd30 (scd30) 
activation molecule early phase hiv-1 infection, investigate the
possible correlation evolution aids.
methods: scd30 values determined enzyme-linked immunosorbent assay
(elisa) serum samples collected time first evidence hiv-1
infection 110 individuals median follow-up 56 months (range, 12-88
months), a1 (74 cases) a2 (36 cases) stages 1993 revised centers
for disease control prevention classification. data evaluated using 
established clinical immunological parameters, including circulating cd4+
t-cell count. controls 110 blood donors 51 hiv-1-negative subjects
belonging groups risk hiv-1 infection.
results: elevated scd30 levels (> 20 u/ml) found 83.6% hiv-1-infected 
cases 47% at-risk seronegatives. data analysis revealed that
hiv-1-infected patients higher scd30 levels (> 35 u/ml) experienced faster
disease progression (p = 0.0002). also case patients the
earliest stage (a1) hiv infection (p = 0.0027). latter cases the
predictive value scd30 independent initial absolute number of
circulating cd4+ lymphocytes.
conclusions: serum levels scd30 increased large majority of
patients early phase hiv-1 infection represent indicator of
progression aids independent prognostic parameters.

doi: 10.1097/00002030-199406000-00003 
pmid: 8086130  [indexed medline]

